The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback